Long-form guides, side-effect deep-dives, and protocol comparisons for men’s health. No paid posts. No “transform your life” copy. We write what we’d want to read before making a treatment decision — for ourselves or someone in our family. Browse by category, search by keyword, or read everything we’ve published.
Both platelet-rich plasma (PRP) injections and low-intensity shockwave therapy (Li-ESWT) produce statistically measurable improvements in erectile function scores—but neither has cleared the bar required for guideline-endorsed treatment, and neither is FDA-approved for erectile…
Viagra (sildenafil) remains the clear first-line choice for most men with erectile dysfunction — guideline-endorsed, fast-acting, and backed by decades of randomized trial data.
Daily tadalafil at 5 mg produces modestly higher rates of successful intercourse than on-demand dosing and is the only PDE5 inhibitor regimen FDA-approved for both erectile dysfunction and lower urinary tract symptoms from benign prostatic hyperplasia.
Stendra (avanafil) wins on speed; Cialis (tadalafil) wins on flexibility and cost. For most men, those two sentences settle the choice — but the details matter enough to read past them.
Sildenafil not working doesn't mean you're out of options — it often means you haven't found the right option yet. Research consistently shows that 25–35% of men report inadequate response to Viagra, but a large fraction of those are fixable with better technique, a different…
Tadalafil lasts significantly longer than sildenafil — up to 36 hours versus 4–6 hours — and that difference comes down to a single pharmacokinetic fact: tadalafil's half-life is roughly 17.5 hours compared to sildenafil's 3–5 hours.
Tadalafil (Cialis) and vardenafil (Levitra) are both proven PDE5 inhibitors, but they serve different sexual lifestyles — and choosing between them comes down to how often you have sex, whether you also have urinary symptoms, and how much you want to plan around a pill.
For daily ED therapy, Cialis (tadalafil) 2.5–5 mg once daily is the clear evidence-based choice — it's the only PDE5 inhibitor with FDA approval specifically for that indication.
Two sessions a week—totaling roughly 30–60 minutes—appears to be the dose at which resistance training delivers its largest mortality benefit. Beyond that threshold, returns diminish fast; below it, you're leaving meaningful protection on the table.
Several legitimate non-prescription approaches to erectile dysfunction are backed by controlled trial data — but the gap between evidence and marketing claims is wide. Here's what the research actually supports, ranked by strength of evidence.
Low-intensity shockwave therapy (LI-ESWT) produces real, measurable improvements in erectile function for men with mild-to-moderate vasculogenic ED — but the gains are modest, durability past 12 months is uncertain, and the FDA still classifies it as investigational.
Ready to start a protocol?
Connect with vetted online providers for TRT, GLP-1, ED treatment, and more.
